TSHA
Taysha Gene Therapies Inc
Price:  
2.45 
USD
Volume:  
726,725
United States | Biotechnology

TSHA Net Margin

As of 2025-07-07, the Net Margin of Taysha Gene Therapies Inc (TSHA) is -1071.6%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

TSHA Net Margin - Historical Value
DateValue
2024-12-31 -1071.6%
2023-12-31 -722.1%
2022-12-31 -6640.4%
2021-12-31 -
2020-12-31 -
2019-12-31 -
-
-
-
-
TSHA Net Margin - Peers Comparison